Pharmaxis lodges TGA application to market Bronchitol for CF in Australia

16th Dec 09

Release Date: 16/12/2009 12:00am

Pharmaxis today announced that it had submitted an application with the Therapeutic Goods Administration (TGA) to market Bronchitol in Australia for the treatment of cystic fibrosis.


Read full media release - pdf

Categories: News and Media